Shuttle Pharmaceuticals shares surge 10.14% intraday after $3.5M public offering to fund marketing and working capital.

Shuttle Pharmaceuticals (NASDAQ: SHPH) surged 10.14% intraday following the announcement of a $3.5 million public offering. The company plans to allocate up to $1.5 million of the proceeds to marketing efforts, with the remainder designated for working capital and general corporate purposes. The offering, set to close on March 9, 2026, includes 2,238,800 shares of common stock and pre-funded warrants to purchase 4,761,200 additional shares, underwritten by E.F. Hutton & Co. The news directly relates to the stock’s performance, as the capital raise signals strategic investment in growth initiatives, including marketing, aligning with positive market sentiment. Other news items, such as unrelated shuttle services or regulatory challenges for Uber, held no material impact on SHPH’s price movement.